A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects

Clinical trial NCT02198651 · COMPLETED

Trial details

NCT number: NCT02198651
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis Musculoskeletal and Connective Tissue Diseases

Start date: 2015-01-05
Primary completion: 2018-05-03
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.